BREAKING----> US Tariff Threat Is Back, US Senate Approves 100% Tariff Power on India Over Russian Oil

A fresh trade-war risk has emerged for India. The US Senate has passed the “Lindsey O. Graham Sanctioning Russia and Iran Act of 2026” by an 86–11 vote, giving the US President the authority to impose tariffs of up to 100% on imports from countries that continue to buy significant amounts of Russian oil and gas, including India. But there is an important distinction: This is NOT a 100% tariff imposed on India yet. The bill still has to move through the US House of Representatives, and even if enacted, the tariff would be a presidential power rather than an automatic levy. ------->Which Indian Sectors Could Face Pressure? If such tariffs are eventually implemented, the impact would likely be highest on businesses with significant exposure to the US market. Textiles & Apparel • $GOKEX • !Kitex Garments • !Pearl US demand is important for several Indian textile exporters, making tariff developments particularly relevant. Chemicals • !SRF • !PI Industries • !Navin Fluorine • !Aarti Industries Chemical exporters with meaningful US exposure could face pressure if additional tariffs are imposed. Pharma Indian pharmaceutical companies have substantial exposure to the US market. However, the exact impact would depend on which products are covered and whether exemptions are provided. Stocks to monitor: • !Sun Pharma • !Dr. Reddy's Laboratories • !Lupin • !Zydus Lifesciences @@But There Is Still a Long Way to Go The Senate vote is significant, but investors should not treat it as an immediate 100% tariff. The bill now faces the US House, where there are already concerns about giving the President such broad tariff powers. Therefore, the next major triggers will be: US House approval → Presidential action → Final tariff scope → Exemptions/waivers → India-US negotiations -----> Bottom Line 100% Tariff Threat, Not 100% Tariff Yet. The US Senate's decision has raised a fresh risk for Indian exporters,